(NVS) Novartis - Performance 20.4% in 12m
Compare NVS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
55.90%
#12 in Group
Rel. Strength
80.41%
#1565 in Universe
Total Return 12m
20.39%
#32 in Group
Total Return 5y
62.42%
#26 in Group
P/E 18.9
49th Percentile in Group
P/E Forward 13.6
48th Percentile in Group
PEG 1.29
62th Percentile in Group
FCF Yield 5.84%
90th Percentile in Group
12m Total Return: NVS (20.4%) vs XLV (-3.4%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
7.23% | 182% | 396% | 50.6 | 37.7 | 0.61 | 61.4% | 10.7% |
| LLY NYSE Eli Lilly |
-2.33% | 12.6% | 444% | 71.9 | 36.8 | 1.22 | 40.3% | 34.5% |
| NVS NYSE Novartis |
-1.42% | 20.4% | 62.4% | 18.9 | 13.6 | 1.29 | 36.2% | 11.6% |
| SFZN SW Siegfried Holding |
-1.55% | 0.98% | 99% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-5.79% | 1.95% | 60.7% | 24 | 20.2 | 1.47 | -20.8% | -17% |
| NOVN SW Novartis |
-8.67% | 7.45% | 35% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
| SAN PA Sanofi |
-14.3% | 7.15% | 23.5% | 20.7 | 10.9 | 0.88 | -22.1% | -24.8% |
| SOBI ST Swedish Orphan Biovitrum |
-9.44% | 0.08% | 38.7% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
Performance Comparison: NVS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NVS
| Total Return (including Dividends) | NVS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -1.42% | -9.22% | -8.88% |
| 3 Months | 14.83% | -6.61% | -14.53% |
| 12 Months | 20.39% | -3.42% | 4.14% |
| 5 Years | 62.42% | 44.91% | 98.04% |
| Trend Score (consistency of price movement) | NVS | XLV | S&P 500 |
| 1 Month | -47.0% | -82.9% | -74.2% |
| 3 Months | 71.6% | -44.4% | -89.4% |
| 12 Months | 16.8% | -3.9% | 64% |
| 5 Years | 87.5% | 90% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #33 | 8.59% | 8.19% |
| 3 Month | #14 | 23.0% | 34.4% |
| 12 Month | #32 | 24.7% | 15.6% |
| 5 Years | #26 | 12.1% | -18.0% |
FAQs
Does NVS Novartis outperforms the market?
Yes,
over the last 12 months NVS made 20.39%, while its related Sector, the Health Care Sector SPDR (XLV) made -3.42%.
Over the last 3 months NVS made 14.83%, while XLV made -6.61%.
Over the last 3 months NVS made 14.83%, while XLV made -6.61%.
Performance Comparison NVS vs Indeces and Sectors
NVS vs. Indices NVS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.67% | 7.46% | 10.3% | 16.3% |
| US NASDAQ 100 | QQQ | 6.32% | 8.37% | 11.3% | 16.4% |
| US Dow Jones Industrial 30 | DIA | 6.81% | 7.59% | 9.38% | 19.0% |
| German DAX 40 | DAX | -0.13% | 5.93% | -9.80% | 2.40% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.52% | 2.14% | 4.50% | 12.6% |
| Hongkong Hang Seng | HSI | 0.87% | 6.76% | 5.55% | 6.45% |
| India NIFTY 50 | INDA | -2.87% | -4.39% | 3.93% | 17.5% |
| Brasil Bovespa | EWZ | 0.23% | 3.74% | 5.36% | 32.6% |
NVS vs. Sectors NVS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.02% | 7.96% | 1.37% | 8.33% |
| Consumer Discretionary | XLY | 6.15% | 6.94% | 7.37% | 13.6% |
| Consumer Staples | XLP | 1.76% | -4.18% | -1.77% | 9.68% |
| Energy | XLE | 0.74% | 12.1% | 9.40% | 34.6% |
| Financial | XLF | 4.17% | 5.95% | 1.55% | 6.95% |
| Health Care | XLV | 5.30% | 7.80% | 10.6% | 23.8% |
| Industrial | XLI | 4.53% | 5.68% | 9.97% | 18.0% |
| Materials | XLB | 3.38% | 5.45% | 16.1% | 29.4% |
| Real Estate | XLRE | 1.42% | 2.55% | 7.00% | 7.07% |
| Technology | XLK | 7.13% | 10.6% | 17.7% | 23.0% |
| Utilities | XLU | 3.26% | 1.48% | 4.50% | 1.88% |
| Aerospace & Defense | XAR | 3.94% | 1.73% | 1.49% | -0.16% |
| Biotech | XBI | 2.34% | 11.9% | 22.0% | 30.1% |
| Homebuilder | XHB | 4.26% | 7.12% | 25.6% | 31.8% |
| Retail | XRT | 2.67% | 3.28% | 13.0% | 27.1% |